PER2 suppresses glioma progression through physical association with KRAS and attenuation of PI3K-AKT-mTOR pathway activation
Glioblastoma (GBM) is the most aggressive primary brain tumor with poor prognosis. The circadian gene PER2 has been reported to exhibit tumor-suppressive functions, while KRAS is a key oncogenic driver. This study aims to investigate the mechanistic interaction between PER2 and KRAS in gliomagenesis. PER2 expression wa...